Last updated: April 25, 2026
Who Supplies TRICOR (Fenofibrate)?
TRICOR is a brand-name pharmaceutical with the active ingredient fenofibrate. Based on publicly indexed information, AbbVie is the U.S. marketing authorization holder for TRICOR, with Patheon (and legacy units of Thermo Fisher Scientific) identified as a manufacturing/supply partner in multiple global listings tied to fenofibrate products.
Core supply chain facts (public indexing):
- Brand/Holder (U.S.): AbbVie (TRICOR, fenofibrate)
- Active ingredient: Fenofibrate
- Manufacturing/supply partners identified in public listings: Patheon (Thermo Fisher group), plus legacy manufacturing entries linked to Thermo Fisher facilities across fenofibrate-related NDA/ANDA product supply documents and cataloging records.
Who is the marketing holder for TRICOR?
- AbbVie is listed as the marketing authorization holder for TRICOR in U.S. drug product records.
Which suppliers manufacture or supply TRICOR-grade fenofibrate?
Public regulatory/catalog records for TRICOR and fenofibrate products consistently point to Patheon as a manufacturing partner within the Thermo Fisher network, with additional plant-linked entries tied to the Thermo Fisher supply chain history.
Named supplier(s) appearing in public listings:
- Patheon (Thermo Fisher Scientific group)
- Thermo Fisher Scientific legacy manufacturing network (plant-linked entries that feed fenofibrate supply listings tied to AbbVie/brand supply, where plant operators are shown as Thermo Fisher entities under historical naming and consolidation)
How do TRICOR supply assignments show up in public listings?
Public-facing listings typically show one or more of the following, depending on the dataset:
- Manufacturing site owner/operator (the entity physically producing the dosage form)
- Marketing authorization holder (the company responsible for the brand)
- Labeler/holder and sometimes packaging vendors
- Global dossier/manufacturing statements where the manufacturing partner differs by strength, dosage form, or region
For TRICOR, the “who supplies” question resolves to a two-layer answer:
- AbbVie is the brand holder in the U.S.
- Patheon is repeatedly identified as a manufacturing partner for fenofibrate dosage forms in indexed product records.
Suppliers snapshot for TRICOR (fenofibrate)
| Layer |
Supplier / Holder |
What they are |
Evidence type (public indexing) |
| Marketing authorization / brand holder |
AbbVie |
Holds the branded product authorization and is the labeler/holder for TRICOR in the U.S. |
U.S. drug product/label holder listings |
| Manufacturing / supply partner |
Patheon (Thermo Fisher) |
Produces fenofibrate dosage forms for brand supply |
Indexed manufacturing partner references in product catalogs/regulatory listings |
| Manufacturing network |
Thermo Fisher Scientific legacy facilities |
Plant-operator entity appears in historical supply entries for fenofibrate products |
Facility-operator naming in indexed manufacturing records |
What TRICOR strength(s) change supply?
TRICOR in the U.S. is typically supplied in multiple strengths. In many branded pharma supply chains, strength changes can alter the specific manufacturing site, while keeping the same contract manufacturer group.
Public indexing for fenofibrate brand supply indicates:
- Manufacturing partner group stays consistent at the group level (Patheon/thermo group), while
- Plant-level assignments can vary by strength, packaging configuration, or region.
Key Takeaways
- AbbVie is the marketing authorization holder for TRICOR in the U.S.
- Patheon (Thermo Fisher Scientific group) is the most consistently identified manufacturing/supply partner in public product indexing for fenofibrate brand supply records.
- Some indexed records show Thermo Fisher legacy plant/operator entities tied to fenofibrate manufacturing assignments, reflecting facility naming and consolidation history.
FAQs
1) Is TRICOR manufactured by AbbVie?
Public indexing points to contract manufacturing rather than AbbVie-operated production, with Patheon identified as a manufacturing partner in supply records tied to fenofibrate products.
2) Who manufactures fenofibrate for TRICOR under contract?
Patheon is the supplier consistently appearing in indexed manufacturing/supply partner references for fenofibrate products associated with TRICOR supply.
3) Does the supplier change by TRICOR strength?
At the group level, the supplier relationship often stays within the same contract manufacturing network. At the plant level, strength-specific assignments can shift in indexed listings.
4) Where do these supplier relationships appear publicly?
In U.S. drug product/label holder and manufacturing partner listings, plus cataloged dossier-style records where contract manufacturing sites and operators are indexed.
5) Is “TRICOR supplier” different from “fenofibrate supplier”?
For supply chain purposes, TRICOR-grade fenofibrate is produced via the same commercial API and dosage-form supply system used for branded fenofibrate products. The sponsor/holder is AbbVie, while the manufacturing partner is typically the contract manufacturer identified for the dosage form.
References (APA)
[1] FDA. (n.d.). Drugs@FDA: Tricor (fenofibrate) (Drug product information). U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/
[2] FDA. (n.d.). Drug product labeling and manufacturer/labeler listings for TRICOR (fenofibrate). U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/
[3] Thermo Fisher Scientific/Patheon corporate and facility-history indexing as reflected in public regulatory product catalogs for contract manufacturing relationships tied to fenofibrate dosage forms (as captured in indexed FDA-facing product records).
